Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Dow
Cerilliant
Moodys
Cipla
McKinsey
AstraZeneca
Healthtrust
Covington

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,158,580

« Back to Dashboard

Which drugs does patent 8,158,580 protect, and when does it expire?

Patent 8,158,580 protects VIBATIV and is included in one NDA.

This patent has eighty-eight patent family members in thirty-four countries.
Summary for Patent: 8,158,580
Title:Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
Abstract: Disclosed are pharmaceutical compositions containing a cyclodextrin and a therapeutically effective amount of a glycopeptide antibiotic or a salt thereof. Also disclosed are methods of treating a bacterial disease in a mammal by administering such pharmaceutical compositions.
Inventor(s): Judice; J. Kevin (El Granada, CA), Shaw; Jeng-Pyng (Saratoga, CA), Mu; YongQi (Los Altos, CA), Conner; Michael W. (Half Moon Bay, CA), Pace; John L. (San Anselmo, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Application Number:12/431,940
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 8,158,580

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-001 Sep 11, 2009 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Theravance Biopharma VIBATIV telavancin hydrochloride POWDER;IV (INFUSION) 022110-002 Sep 11, 2009 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,158,580

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,067,483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin ➤ Try a Free Trial
7,244,705 Polyacid glycopeptide derivatives ➤ Try a Free Trial
6,620,781 Glycopeptide carboxy-saccharide derivatives ➤ Try a Free Trial
6,828,299 Polyhydroxy glycopeptide derivatives ➤ Try a Free Trial
6,887,976 Glycopeptide phosphonate derivatives ➤ Try a Free Trial
7,700,550 Glycopeptide phosphonate derivatives ➤ Try a Free Trial
7,265,086 Glycopeptide carboxy-saccharide derivatives ➤ Try a Free Trial
7,026,288 Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin ➤ Try a Free Trial
6,831,150 Reductive alkylation process ➤ Try a Free Trial
6,872,701 Glycopeptide phosphonate derivatives ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,158,580

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Ukraine 75083 ➤ Try a Free Trial
Taiwan I305209 ➤ Try a Free Trial
Slovakia 287470 ➤ Try a Free Trial
Slovakia 18522002 ➤ Try a Free Trial
Slovenia 1292612 ➤ Try a Free Trial
Slovenia 1278549 ➤ Try a Free Trial
Slovenia 1276759 ➤ Try a Free Trial
Serbia 50499 ➤ Try a Free Trial
Yugoslavia 96902 ➤ Try a Free Trial
Portugal 1292612 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Dow
Mallinckrodt
Federal Trade Commission
Deloitte
Daiichi Sankyo
Medtronic
US Department of Justice
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot